These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

172 related articles for article (PubMed ID: 3165255)

  • 1. Experiments with tissue cultures from a human ovarian serous cystadenocarcinoma producing cancer antigen 125 (CA125), tissue polypeptide antigen (TPA) and carcinoembryonic antigen (CEA).
    Fukazawa I; Inaba N; Ota Y; Sato N; Shirotake S; Iwasawa H; Sekiya S; Takamizawa H; Suzuki N; Tokita H
    Arch Gynecol Obstet; 1988; 243(2):69-81. PubMed ID: 3165255
    [TBL] [Abstract][Full Text] [Related]  

  • 2. [Relationship between serum levels and immunohistological tissue levels of CA 125 and CEA in epithelial ovarian cancers: its implications for tumor cell type specificity].
    Oishi T; Maruo T; Iwasaki M; Mochizuki M
    Nihon Sanka Fujinka Gakkai Zasshi; 1986 Sep; 38(9):1595-604. PubMed ID: 3464659
    [TBL] [Abstract][Full Text] [Related]  

  • 3. [A study of localizations and serum data; four tumor markers (CA125, CA19-9, CEA and TPA) in ovarian cancers].
    Kataoka A; Yakushiji M
    Nihon Gan Chiryo Gakkai Shi; 1990 Jan; 25(1):47-54. PubMed ID: 2157782
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Serum levels of six tumor markers in patients with benign and malignant gynecological disease.
    Fukazawa I; Inaba N; Ota Y; Sato N; Shirotake S; Iwasawa H; Sato T; Takamizawa H; Wiklund B
    Arch Gynecol Obstet; 1988; 243(2):61-8. PubMed ID: 3401042
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Preoperative determination of several serum tumor markers in patients with primary epithelial ovarian carcinoma.
    Kudoh K; Kikuchi Y; Kita T; Tode T; Takano M; Hirata J; Mano Y; Yamamoto K; Nagata I
    Gynecol Obstet Invest; 1999; 47(1):52-7. PubMed ID: 9852392
    [TBL] [Abstract][Full Text] [Related]  

  • 6. [Diagnostic usefulness of stepwise discriminant analysis employing the values of CA125, TPA, IAP, CEA and ferritin in sera measured simultaneously for gynecological malignant neoplasms].
    Yabushita H; Masuda T; Hattori A; Noguchi M; Ito Y; Nakanishi M; Ishihara M
    Nihon Sanka Fujinka Gakkai Zasshi; 1985 Sep; 37(9):1883-92. PubMed ID: 2997349
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Relation between serum levels of tissue polypeptide antigen (TPA) and cancer antigen 125 (CA125) and their immunohistochemical identification in benign and malignant gynecological disease.
    Fukazawa I; Inaba N; Ota Y; Sato N; Shirotake S; Iwasawa H; Sato T; Takamizawa H; Wiklund B
    Arch Gynecol Obstet; 1988; 243(1):41-50. PubMed ID: 3165614
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Establishment and characterization of a human ovarian serous cystadenocarcinoma cell line that produces the tumor markers CA-125 and tissue polypeptide antigen.
    Imai S; Kiyozuka Y; Maeda H; Noda T; Hosick HL
    Oncology; 1990; 47(2):177-84. PubMed ID: 2314830
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Combination assay of CA125, TPA, IAP, CEA, and ferritin in serum for ovarian cancer.
    Yabushita H; Masuda T; Ogawa A; Noguchi M; Ishihara M
    Gynecol Oncol; 1988 Jan; 29(1):66-75. PubMed ID: 3422208
    [TBL] [Abstract][Full Text] [Related]  

  • 10. [Establishment and characterization of a human ovarian adenocarcinoma cell line OC-8611].
    Huang JS
    Zhonghua Zhong Liu Za Zhi; 1989 Nov; 11(6):416-8. PubMed ID: 2634538
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Clinical usefulness of sialyl SSEA-1 antigen as tumor marker for ovarian cancer as compared with CA125, CA19-9, TPA, IAP, CEA and ferritin.
    Yabushita H; Sawaguchi K; Hieda S; Ogawa A; Tomatsu A; Noguchi M; Ishihara M
    Nihon Sanka Fujinka Gakkai Zasshi; 1989 Feb; 41(2):217-24. PubMed ID: 2566639
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Morphologic characteristics, proliferation, and tumor marker expression of two human ovarian carcinoma cell lines in three-dimensional culture.
    Morimitsu Y; Yano H; Kojiro M
    Gynecol Oncol; 1993 Feb; 48(2):155-64. PubMed ID: 8428685
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Cancer antigen 125, tissue polypeptide antigen, carcinoembryonic antigen, and beta-chain human chorionic gonadotropin as serum markers of epithelial ovarian carcinoma.
    Panza N; Pacilio G; Campanella L; Peluso G; Battista C; Amoriello A; Utech W; Vacca C; Lombardi G
    Cancer; 1988 Jan; 61(1):76-83. PubMed ID: 2446734
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Comparative measurement of ovarian carcinoma antigen and carcinoembryonic antigen in the serum of ovarian cancer.
    Yuan CC; Ng HT; Tsai LC; Jeng FS; Yeh SH; Tsai YC
    Zhonghua Min Guo Wei Sheng Wu Ji Mian Yi Xue Za Zhi; 1987 Aug; 20(3):190-7. PubMed ID: 3480793
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Tumor markers in bronchogenic carcinoma. Superiority of tissue polypeptide antigen to carcinoembryonic antigen and carbohydrate antigenic determinant 19-9.
    Buccheri GF; Ferrigno D; Sartoris AM; Violante B; Vola F; Curcio A
    Cancer; 1987 Jul; 60(1):42-50. PubMed ID: 3472637
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Clinical value of CA125, CA19-9, CEA, CA72-4, and TPA in borderline ovarian tumor.
    Tamakoshi K; Kikkawa F; Shibata K; Tomoda K; Obata NH; Wakahara F; Tokuhashi Y; Ishikawa H; Kawai M; Tomoda Y
    Gynecol Oncol; 1996 Jul; 62(1):67-72. PubMed ID: 8690294
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Measurement of CEA, TPA, neopterin, CA125, CA153 and CA199 in sera of pregnant women, umbilical cord blood and amniotic fluid.
    Lellé RJ; Henkel E; Leinemann D; Goeschen K
    Gynecol Obstet Invest; 1989; 27(3):137-42. PubMed ID: 2737547
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Differential immunocytochemical localization of tissue polypeptide antigen (TPA) and carcinoembryonic antigen (CEA) in breast cancer.
    Björklund V; Björklund B
    Cancer Detect Prev; 1983; 6(1-2):193-8. PubMed ID: 6883380
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Combined evaluation of some tumor associated antigens in the monitoring of integrated surgical and chemotherapeutic treatment of epithelial ovarian cancer.
    Fioretti P; Gadducci A; Ferdeghini M; Bartolini T; Scatena P; Facchini V; Bianchi R
    Eur J Gynaecol Oncol; 1986; 7(3):200-5. PubMed ID: 3465535
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Expression of CEA, CA125, CA19-9 and human milk fat globule membrane antigen in ovarian tumours.
    Macdonald F; Bird R; Stokes H; Russell B; Crocker J
    J Clin Pathol; 1988 Mar; 41(3):260-4. PubMed ID: 3162916
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 9.